Keywords: wyeth, 2nd-qtr, net, income, climbs, new, jersey

Wyeth's 2nd-qtr net income climbs 12.5%

Article | 30 July 2007

Print This

New Jersey, USA-based Wyeth said that strong sales of its anti-inflammatory agent Enbrel (etanercept), outside the USA and Canada, and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in